Comparing UroLift Experience Against Rezum (C.L.E.A.R. Study)

Brief description of study

The purpose of this study is to compare two different minimally invasive procedures often used to treat the symptoms of benign prostatic hyperplasia (BPH): the UroLiftTM System procedure and the RezumTM System procedure. Both of these are FDA-approved.

Clinical Study Identifier: s20-01235

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.